Management of CAD Before and After TAVR
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Abiomed; Boston Scientific Corporation; Daiichi-Sankyo/Elil Lilly and Company; Medtronic; Microport; Edwards Lifesciences